This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lebrun, J.-J. Articles by Vale, W. Search for Related Content PubMed PubMed Citation Articles by Lebrun, J.-J. Articles by Vale, W.

Roles of Pathway-Specific and Inhibitory Smads in Activin Receptor Signaling

Clayton Foundation Laboratories for Peptide Biology Salk Institute for Biological Studies La Jolla, California 92037

Activins and other members of the transforming growth factor-ß-like superfamily of growth factors transduce their signals by interacting with two types of receptor serine/threonine kinases. The Smad proteins, a new family of intracellular mediators are involved in the signaling pathways of these receptors, but the initial stages of their activation as well as their specific functions remain to be defined. We report here that the pathway-specific Smad2 and 3 can form a complex with the activin receptor in a ligand-dependent manner. This complex formation is rapid but also transient. Indeed, soon after their association with the activin receptor, Smad2 and Smad3 are released into the cytoplasm where they interact with the common partner Smad4. These Smad complexes then mediate activin-induced transcription. Finally, we show that the inhibitory Smad7 can prevent the association of the two pathway-specific Smads with the activin receptor complex, thereby blocking the activin signal.

This article has been cited by other articles:

				S. M. McGillivray, V. G. Thackray, D. Coss, and P. L. Mellon Activin and Glucocorticoids Synergistically Activate Follicle-Stimulating Hormone {beta}-Subunit Gene Expression in the Immortalized L{beta}T2 Gonadotrope Cell Line Endocrinology, February 1, 2007; 148(2): 762 - 773. [Abstract] [Full Text] [PDF]

				C. de Guise, A. Lacerte, S. Rafiei, R. Reynaud, M. Roy, T. Brue, and J.-J. Lebrun Activin Inhibits the Human Pit-1 Gene Promoter through the p38 Kinase Pathway in a Smad-Independent Manner Endocrinology, September 1, 2006; 147(9): 4351 - 4362. [Abstract] [Full Text] [PDF]

				T. Tobimatsu, H. Kaji, H. Sowa, J. Naito, L. Canaff, G. N. Hendy, T. Sugimoto, and K. Chihara Parathyroid Hormone Increases {beta}-Catenin Levels through Smad3 in Mouse Osteoblastic Cells Endocrinology, May 1, 2006; 147(5): 2583 - 2590. [Abstract] [Full Text] [PDF]

				N. R. Dunn, C. H. Koonce, D. C. Anderson, A. Islam, E. K. Bikoff, and E. J. Robertson Mice exclusively expressing the short isoform of Smad2 develop normally and are viable and fertile Genes & Dev., January 1, 2005; 19(1): 152 - 163. [Abstract] [Full Text] [PDF]

				H. Sowa, H. Kaji, G. N. Hendy, L. Canaff, T. Komori, T. Sugimoto, and K. Chihara Menin Is Required for Bone Morphogenetic Protein 2- and Transforming Growth Factor {beta}-regulated Osteoblastic Differentiation through Interaction with Smads and Runx2 J. Biol. Chem., September 24, 2004; 279(39): 40267 - 40275. [Abstract] [Full Text] [PDF]

				A. Lacerte, E.-H. Lee, R. Reynaud, L. Canaff, C. de Guise, D. Devost, S. Ali, G. N. Hendy, and J.-J. Lebrun Activin Inhibits Pituitary Prolactin Expression and Cell Growth through Smads, Pit-1 and Menin Mol. Endocrinol., June 1, 2004; 18(6): 1558 - 1569. [Abstract] [Full Text] [PDF]

				N. R. Dunn, S. D. Vincent, L. Oxburgh, E. J. Robertson, and E. K. Bikoff Combinatorial activities of Smad2 and Smad3 regulate mesoderm formation and patterning in the mouse embryo Development, April 15, 2004; 131(8): 1717 - 1728. [Abstract] [Full Text] [PDF]

				D. J. Bernard Both SMAD2 and SMAD3 Mediate Activin-Stimulated Expression of the Follicle-Stimulating Hormone {beta} Subunit in Mouse Gonadotrope Cells Mol. Endocrinol., March 1, 2004; 18(3): 606 - 623. [Abstract] [Full Text] [PDF]

				R. B. Billiar, J. B. St. Clair, N. C. Zachos, M. G. Burch, E. D. Albrecht, and G. J. Pepe Localization and Developmental Expression of the Activin Signal Transduction Proteins Smads 2, 3, and 4 in the Baboon Fetal Ovary Biol Reprod, March 1, 2004; 70(3): 586 - 592. [Abstract] [Full Text] [PDF]

				H. Sowa, H. Kaji, M. F. Iu, T. Tsukamoto, T. Sugimoto, and K. Chihara Parathyroid Hormone-Smad3 Axis Exerts Anti-apoptotic Action and Augments Anabolic Action of Transforming Growth Factor {beta} in Osteoblasts J. Biol. Chem., December 26, 2003; 278(52): 52240 - 52252. [Abstract] [Full Text] [PDF]

				Y. Wang and W. Ge Spatial Expression Patterns of Activin and Its Signaling System in the Zebrafish Ovarian Follicle: Evidence for Paracrine Action of Activin on the Oocytes Biol Reprod, December 1, 2003; 69(6): 1998 - 2006. [Abstract] [Full Text] [PDF]

				S. L. Mellor, E. M. A. Ball, A. E. O'Connor, J.-F. Ethier, M. Cranfield, J. F. Schmitt, D. J. Phillips, N. P. Groome, and G. P. Risbridger Activin {beta}C-Subunit Heterodimers Provide a New Mechanism of Regulating Activin Levels in the Prostate Endocrinology, October 1, 2003; 144(10): 4410 - 4419. [Abstract] [Full Text] [PDF]

				H. Sowa, H. Kaji, L. Canaff, G. N. Hendy, T. Tsukamoto, T. Yamaguchi, K. Miyazono, T. Sugimoto, and K. Chihara Inactivation of Menin, the Product of the Multiple Endocrine Neoplasia Type 1 Gene, Inhibits the Commitment of Multipotential Mesenchymal Stem Cells into the Osteoblast Lineage J. Biol. Chem., May 30, 2003; 278(23): 21058 - 21069. [Abstract] [Full Text] [PDF]

				C. Mukasa, M. Nomura, T. Tanaka, K. Tanaka, Y. Nishi, T. Okabe, K. Goto, T. Yanase, and H. Nawata Activin Signaling through Type IB Activin Receptor Stimulates Aromatase Activity in the Ovarian Granulosa Cell-Like Human Granulosa (KGN) Cells Endocrinology, April 1, 2003; 144(4): 1603 - 1611. [Abstract] [Full Text] [PDF]

				M. I. Suszko, D. J. Lo, H. Suh, S. A. Camper, and T. K. Woodruff Regulation of the Rat Follicle-Stimulating Hormone {beta}-Subunit Promoter by Activin Mol. Endocrinol., March 1, 2003; 17(3): 318 - 332. [Abstract] [Full Text] [PDF]

				H. Sowa, H. Kaji, T. Yamaguchi, T. Sugimoto, and K. Chihara Activations of ERK1/2 and JNK by Transforming Growth Factor beta Negatively Regulate Smad3-induced Alkaline Phosphatase Activity and Mineralization in Mouse Osteoblastic Cells J. Biol. Chem., September 20, 2002; 277(39): 36024 - 36031. [Abstract] [Full Text] [PDF]

				S. A. Pangas, A. W. Rademaker, D. A. Fishman, and T. K. Woodruff Localization of the Activin Signal Transduction Components in Normal Human Ovarian Follicles: Implications for Autocrine and Paracrine Signaling in the Ovary J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2644 - 2657. [Abstract] [Full Text] [PDF]

				Y.-G. Chen, H. M. Lui, S.-L. Lin, J. M. Lee, and S.-Y. Ying Regulation of Cell Proliferation, Apoptosis, and Carcinogenesis by Activin Experimental Biology and Medicine, February 1, 2002; 227(2): 75 - 87. [Abstract] [Full Text] [PDF]

				G. P. Risbridger, J. F. Schmitt, and D. M. Robertson Activins and Inhibins in Endocrine and Other Tumors Endocr. Rev., December 1, 2001; 22(6): 836 - 858. [Abstract] [Full Text] [PDF]

				T. El-Hefnawy and A. J. Zeleznik Synergism Between FSH and Activin in the Regulation of Proliferating Cell Nuclear Antigen (PCNA) and Cyclin D2 Expression in Rat Granulosa Cells Endocrinology, October 1, 2001; 142(10): 4357 - 4362. [Abstract] [Full Text] [PDF]

				H. Kaji, L. Canaff, J.-J. Lebrun, D. Goltzman, and G. N. Hendy Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling PNAS, March 7, 2001; (2001) 61358098. [Abstract] [Full Text]

				L. M. Bilezikjian, A. Z. Corrigan, A. L. Blount, Y. Chen, and W. W. Vale Regulation and Actions of Smad7 in the Modulation of Activin, Inhibin, and Transforming Growth Factor-{{beta}} Signaling in Anterior Pituitary Cells Endocrinology, March 1, 2001; 142(3): 1065 - 1072. [Abstract] [Full Text] [PDF]

				M. Funaba and L. S. Mathews Identification and Characterization of Constitutively Active Smad2 Mutants: Evaluation of Formation of Smad Complex and Subcellular Distribution Mol. Endocrinol., October 1, 2000; 14(10): 1583 - 1591. [Abstract] [Full Text]

				C. Osterlund and G. Fried TGF{beta} receptor types I and II and the substrate proteins Smad 2 and 3 are present in human oocytes Mol. Hum. Reprod., June 1, 2000; 6(6): 498 - 503. [Abstract] [Full Text] [PDF]

				A. J. Symes, R. L. Pitts, J. Conover, K. Kos, and J. Coulombe Synergy of Activin and Ciliary Neurotrophic Factor Signaling Pathways in the Induction of Vasoactive Intestinal Peptide Gene Expression Mol. Endocrinol., March 1, 2000; 14(3): 429 - 439. [Abstract] [Full Text]

				K. Tremblay, P. Hoodless, E. Bikoff, and E. Robertson Formation of the definitive endoderm in mouse is a Smad2-dependent process Development, January 7, 2000; 127(14): 3079 - 3090. [Abstract] [PDF]

				A. Zauberman, S. Lapter, and D. Zipori Smad Proteins Suppress CCAAT/Enhancer-binding Protein (C/EBP) beta - and STAT3-mediated Transcriptional Activation of the Haptoglobin Promoter J. Biol. Chem., June 29, 2001; 276(27): 24719 - 24725. [Abstract] [Full Text] [PDF]

				E. Cocolakis, S. Lemay, S. Ali, and J.-J. Lebrun The p38 MAPK Pathway Is Required for Cell Growth Inhibition of Human Breast Cancer Cells in Response to Activin J. Biol. Chem., May 18, 2001; 276(21): 18430 - 18436. [Abstract] [Full Text] [PDF]

				H. Kaji, L. Canaff, J.-J. Lebrun, D. Goltzman, and G. N. Hendy Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling PNAS, March 27, 2001; 98(7): 3837 - 3842. [Abstract] [Full Text] [PDF]